全文获取类型
收费全文 | 2630篇 |
免费 | 236篇 |
国内免费 | 162篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 37篇 |
妇产科学 | 67篇 |
基础医学 | 301篇 |
口腔科学 | 26篇 |
临床医学 | 232篇 |
内科学 | 609篇 |
皮肤病学 | 18篇 |
神经病学 | 295篇 |
特种医学 | 34篇 |
外科学 | 242篇 |
综合类 | 120篇 |
预防医学 | 184篇 |
眼科学 | 12篇 |
药学 | 223篇 |
中国医学 | 14篇 |
肿瘤学 | 603篇 |
出版年
2023年 | 58篇 |
2022年 | 142篇 |
2021年 | 228篇 |
2020年 | 230篇 |
2019年 | 231篇 |
2018年 | 224篇 |
2017年 | 154篇 |
2016年 | 187篇 |
2015年 | 152篇 |
2014年 | 335篇 |
2013年 | 218篇 |
2012年 | 162篇 |
2011年 | 170篇 |
2010年 | 95篇 |
2009年 | 104篇 |
2008年 | 101篇 |
2007年 | 62篇 |
2006年 | 46篇 |
2005年 | 38篇 |
2004年 | 23篇 |
2003年 | 11篇 |
2002年 | 6篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 3篇 |
1997年 | 12篇 |
1996年 | 3篇 |
1995年 | 7篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1990年 | 1篇 |
排序方式: 共有3028条查询结果,搜索用时 312 毫秒
91.
92.
目的 探索全身照射大鼠血浆代谢物变化,为辐射生物标志物研究提供实验依据。方法 应用代谢组学方法筛选辐射差异代谢物并进行初步验证。筛选研究中,大鼠50只(发现集),用60Co γ射线对大鼠进行全身照射,照射剂量为0、1、2、3、5、8 Gy;验证研究中,大鼠25只(验证集),照射剂量为0、0.5、2.5、4、6 Gy。照射后4 h采集外周血液,分离血浆进行代谢组学分析,并测定辐射差异代谢物浓度,用代谢物组合受试者工作特征曲线(ROC)对特定剂量进行分类。结果 共筛选出8个血浆辐射差异代谢物,其中4个(胞嘧啶、己酰基肉碱、十八碳二烯酰基肉碱及棕榈酰基肉碱)在受照后发生上调,变化趋势与验证集一致,区分特定剂量样本曲线下面积(AUC)>0.75。将上述4个代谢物进行组合后,区分0 Gy与>0 Gy、<2 Gy与≥2 Gy、<5 Gy与≥5 Gy样本的AUC值分别为0.96、1和0.94。结论 大鼠受到全身照射后4 h,血浆代谢物发生显著变化,共鉴定出8个辐射差异代谢物,其中胞嘧啶、己酰基肉碱、十八碳二烯酰基肉碱及棕榈酰基肉碱具有良好的稳定性,其组合具有较高的分类准确性,有可能成为特定剂量分类的辐射敏感标志物。 相似文献
93.
目的 探究低剂量电离辐射对医疗机构放射工作人员外周静脉血清中胰岛素样生长因子结合蛋白3(IGFBP-3)表达水平的影响。方法 采用单纯随机抽样法选取183名放射工作人员纳入此次研究,按放射工种分组,其中介入放射学组37例、核医学组43例、放射治疗组48例和诊断放射学组55例。血清IGFBP-3浓度测定采用酶联免疫吸附试验。结果 4个不同工种组间放射工作人员血清IGFBP-3浓度的差异具有统计学意义(F=6.056,P<0.05),其中介入放射学组血清IGFBP-3浓度最高(t=2.815、3.611、3.936,P<0.05);不同年有效剂量组间放射工作人员血清中IGFBP-3的浓度差异具有统计学意义(F=8.380,P<0.05)。随着放射工龄和年有效剂量的增加,放射工作人员血清IGFBP-3浓度呈现上升趋势(rs=0.202、0.151,P<0.05)。结论 血清IGFBP-3表达水平有作为反映长期慢性低剂量电离辐射累积暴露的生物标志物的潜力。 相似文献
94.
目的 探讨半胱氨酸酶抑制剂A(CSTA)在口腔鳞癌中的表达及其与临床病理特征的关系。方法 通过免疫组织化学染色、Western 免疫印迹和实时定量PCR(qRT-PCR)检测CSTA的表达,通过Transwell迁移侵袭实验评估CSTA对口腔鳞癌细胞转移的促进作用。采用SPSS 25.0和GraphPad Prism 8.4.3软件进行数据分析。结果 CSTA在口腔鳞癌中的表达显著低于正常口腔黏膜上皮组织,其表达量与颈淋巴结转移(P=0.028)和肿瘤病理级别呈显著负相关(P=0.001),CSTA低表达的细胞倾向分布于肿瘤侵袭前缘;CSTA低表达组患者总生存期显著短于CSTA高表达组,CSTA过表达可在体外抑制口腔鳞癌细胞迁移与侵袭。结论 CSTA在调控口腔鳞癌颈淋巴转移过程中发挥重要作用,有望成为口腔鳞癌颈淋巴转移的潜在预测和治疗靶标。 相似文献
95.
96.
Th‐17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell–Mediated Rejection 下载免费PDF全文
M. Matignon A. Aissat F. Canoui‐Poitrine C. Grondin C. Pilon D. Desvaux D. Saadoun Q. Barathon M. Garrido V. Audard P. Rémy P. Lang J. Cohen P. Grimbert 《American journal of transplantation》2015,15(10):2718-2725
Although renal transplantation using expanded criteria donors has become a common practice, immune responses related to immunosenescence in those kidney allografts have not been studied yet in humans. We performed a retrospective molecular analysis of the T cell immune response in 43 kidney biopsies from patients with acute T cell–mediated rejection including 25 from recipients engrafted with a kidney from expanded criteria donor and 18 from recipients grafted with optimal kidney allograft. The clinical, transplant and acute T cell–mediated rejection characteristics of both groups were similar at baseline. The expression of RORγt, Il‐17 and T‐bet mRNA was significantly higher in the elderly than in the optimal group (p = 0.02, p = 0.036, and p = 0.01, respectively). Foxp3 mRNA levels were significantly higher in elderly patients experiencing successful acute T cell–mediated rejection reversal (p = 0.03). The presence of IL‐17 mRNA was strongly associated with nonsuccessful reversal in elderly patients (p = 0.008). Patients with mRNA IL17 expression detection and low mRNA Foxp3 expression experienced significantly more treatment failure (87.5%) than patients with no mRNA IL17 expression and/or high mRNA Foxp3 expression (26.7%; p = 0.017). Our study suggests that the Th17 pathway is involved in pathogenesis and prognosis of acute T cell–mediated rejection in recipients of expanded criteria allograft. 相似文献
97.
98.
99.
Mohd Wamique Wahid Ali D. Himanshu Reddy Preeti Vishwakarma Mohd Waseem 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2018,12(6):843-847
Aim
To evaluate the serum paraoxonase 1 activity and determine its association with duration in type 2 Diabetes mellitus patients.Methods
A total of 80 cases from type 2 diabetes mellitus and healthy controls were enrolled in the present case control study. Human serum PON1 concentration was measured by ELISA and western blotting and it activity was determined spectrophotometrically using 4-nitrophenyle acetate. Diagnostic accuracy of serum PON1 to identify type 2 Diabetes mellitus was calculated with ROC analysis.Result
Serum concentration of LDL, VLDL, TG, A1C, FBS and TC levels showed significantly higher levels in type 2 diabetes patients as compared to healthy controls, however there were no significant differences found in the level of HDL. Serum PON1 concentration and activity monitored in patients with >1?year diabetes showed higher level (75.1?±?6.8?ng/mL) as compared to patients with >3?years diabetes (65.24?±?1.6?ng/mL), its level was further decreased in patients with >5 (53.8?±?2.6?ng/mL) and >7?years (48.1?±?2.7?ng/mL) of diabetes. PON1 concentration decreased as the duration of diabetes increased. PON1 level was further decreased due to habits like smoking and alcohol consumption.Conclusion
Serum PON1 levels decrease in states of high oxidative stress like metabolic syndrome, obesity, uncontrolled diabetes, and dyslipidemia. It can be used as diagnostic marker for diabetes mellitus along with increased TG, LDL, VLDL and FBG. 相似文献100.